E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/1/2006 in the Prospect News Biotech Daily.

New Issue: Icon secondary of 1 million ADS fetches $63.5 million at $63.50 each vs. $65.84 close

By Ronda Fears

Memphis, Aug. 1 - A secondary offering of 1 million Icon plc American Depositary Shares was priced at $63.50 each via bookrunner William Blair & Co., LLC. The selling shareholders were Ronan Lambe, one of Icon's co-founders and board member, and Poplar Ltd., the sole beneficial owner of which is John Climax, Icon's other co-founder and chairman.

Dublin, Ireland-based Icon is a contract research organization providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Original issuer:Icon plc ADS
Issue:Secondary offering
Gross proceeds:$63.5 million
Shares:1 million ADS
Greenshoe:525,000 shares
Price:$63.50 per share
Bookrunner:William Blair & Co., LLC
Co-managers:Bear, Stearns & Co. Inc. and Jefferies & Co., Inc
Pricing date:July 31
Settlement date:Aug. 4
Stock symbol:Nasdaq: ICLR
Stock price:$65.84 on July 31

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.